Engineering a designer immunotherapy Tailoring cytokine selectivity by engineering receptor-ligand pairs circumvents toxicity

doi:10.1126/science.aas9434

GSTDTAP > 地球科学

DOI	10.1126/science.aas9434
	Engineering a designer immunotherapy Tailoring cytokine selectivity by engineering receptor-ligand pairs circumvents toxicity
	Mackall, Crystal L.1,2
	2018-03-02
发表期刊	SCIENCE
ISSN	0036-8075
EISSN	1095-9203
出版年	2018
卷号	359 期号:6379 页码:990-991
文章类型	Editorial Material
语种	英语
国家	USA
领域	地球科学 ; 气候变化 ; 资源环境
收录类别	SCI-E ; SSCI
WOS记录号	WOS:000426366200025
WOS关键词	T-CELLS ; LYMPHOBLASTIC-LEUKEMIA ; INTERLEUKIN-2 ; CHEMOTHERAPY ; THERAPY ; ADULTS
WOS类目	Multidisciplinary Sciences
WOS研究方向	Science & Technology - Other Topics
URL	查看原文
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/198080
专题	地球科学资源环境科学气候变化
作者单位	1.Stanford Univ, Dept Pediat & Med, 265 Campus Way,G3141A, Stanford, CA 94305 USA; 2.Stanford Univ, Stanford Canc Inst, 265 Campus Way,G3141A, Stanford, CA 94305 USA
推荐引用方式 GB/T 7714	Mackall, Crystal L.. Engineering a designer immunotherapy Tailoring cytokine selectivity by engineering receptor-ligand pairs circumvents toxicity[J]. SCIENCE,2018,359(6379):990-991.
APA	Mackall, Crystal L..(2018).Engineering a designer immunotherapy Tailoring cytokine selectivity by engineering receptor-ligand pairs circumvents toxicity.SCIENCE,359(6379),990-991.
MLA	Mackall, Crystal L.."Engineering a designer immunotherapy Tailoring cytokine selectivity by engineering receptor-ligand pairs circumvents toxicity".SCIENCE 359.6379(2018):990-991.